From Tumor Drug Persistence to Resistance and the Cancer Resistome


Despite the huge progress in developing potent cancer therapies, too frequently tumor cells persist, giving rise to drug resistance. In this on-demand webinar, Dr. Patrick C. Ma of Penn State Cancer Institute and Dr. Nick Goldner of resistanceBio explore multi-omics approaches to understand resistance mechanisms enabling more durable treatments.